Deoxyribonuclease >2500 Kunitz Units/mg Source : Bovine

Added to your cart

Deoxyribonuclease >2500 Kunitz Units/mg Source : Bovine

Cart subtotal: £0.00

View cart (0) Checkout

#SKU 041160BBI

Get in touch to purchase this product

Contact our team of experts to discuss your requirements

Contact our expert team

Product Details

Deoxyribonuclease (DNase) occurs predominantly in the pancreas, but has also been found in other tissues and in the salivary glands. DNase is an endonuclease enzyme that hydrolyses phosphodiester bonds adjacent to pyrimidine nucleotides of deoxyribonucleic acid (DNA), yielding 5’-phosphate terminated polynucleotides with a free hydroxyl group at the 3’ position.
041160BBI

More information

Attributes

Description

  • Shipping Information
  • Ambient Shipping
  • Abbreviations
  • Dnase
  • Associated Activity
  • Moisture: ≤5% Total Combined Yeast & Mould Count: ≤1000 Total Aerobic Microbial Count: ≤1000
  • Lead Time
  • 12 weeks to 6 months raw material depending
  • Storage
  • -20°C
  • Source
  • Bovine pancreas
  • Activity
  • ≥2500 U/mg Kunitz
  • EC Number
  • 3.1.21.1
  • EINECS
  • 232-667-0
  • Solubility
  • 5mg/mL
  • Systematic Name
  • Deoxyribonucleate 5-oligonucleotidohydrolase

Technical Documents

041160BBI Product Specification (31.5KB)

Product Specification (31.5KB)

Product Information (387.21KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands

diarect.png

The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.

mbs.png

Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.

Newsletter

Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox